Recordati Industria Chimica e Farmaceutica S.p.A. (LON:0KBS)

Market Cap	9.55B
Revenue (ttm)	2.13B
Net Income (ttm)	349.10M
Shares Out	n/a
EPS (ttm)	1.67
PE Ratio	27.37
Forward PE	16.03
Dividend	1.07 (1.98%)
Ex-Dividend Date	May 19, 2025

Volume	4,193
Average Volume	10,623
Open	54.70
Previous Close	54.60
Day's Range	53.65 - 54.80
52-Week Range	44.04 - 60.95
Beta	0.54
RSI	53.24
Earnings Date	Nov 11, 2025

About LON:0KBS

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops REC 0545 for acute decompensation in maple syrup urine diseases; Isturia for endogenous Cushing’s syndrome; Cystadrops for corneal cystine crystal deposits; Carbaglu for hyperammonemia due ...

• Industry: Pharmaceutical Preparations
• Founded: 1926
• Employees: 4,583
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KBS

Financial Performance

In 2024, LON:0KBS's revenue was 2.34 billion, an increase of 12.45% compared to the previous year's 2.08 billion. Earnings were 416.51 million, an increase of 7.01%.

Financial numbers in EUR